2021-2027 Global and Regional Antibody Industry Status and Prospects Professional Market Research Report Standard Version

Publisher Name :
Date: 26-Aug-2021
No. of pages: 175

The global Antibody market was valued at 7970.8 Million USD in 2020 and will grow with a CAGR of 5.13% from 2020 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler - scientists at the Roche-funded Basel Institute for Immunology - who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China. In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12% In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016. The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.

By Market Verdors:

Roche

Johnson & Johnson

Merck

Novartis

AbbVie

Amgen

Pfizer

Bayer

Lilly

Bristol-Myers Squibb

GlaxoSmithKline

Biogen

AstraZeneca

Sanofi

Alexion Pharmaceuticals

Seattle Genetics

By Types:

IgM

IgG

IgA

By Applications:

Therapeutic

Research

Diagnostic

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

2021-2027 Global and Regional Antibody Industry Status and Prospects Professional Market Research Report Standard Version

Table of Contents

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Antibody Market Size Analysis from 2022 to 2027
1.5.1 Global Antibody Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Antibody Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Antibody Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Antibody Industry Impact
Chapter 2 Global Antibody Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antibody (Volume and Value) by Type
2.1.1 Global Antibody Consumption and Market Share by Type (2016-2021)
2.1.2 Global Antibody Revenue and Market Share by Type (2016-2021)
2.2 Global Antibody (Volume and Value) by Application
2.2.1 Global Antibody Consumption and Market Share by Application (2016-2021)
2.2.2 Global Antibody Revenue and Market Share by Application (2016-2021)
2.3 Global Antibody (Volume and Value) by Regions
2.3.1 Global Antibody Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Antibody Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Antibody Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Antibody Consumption by Regions (2016-2021)
4.2 North America Antibody Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Antibody Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Antibody Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Antibody Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Antibody Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Antibody Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Antibody Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Antibody Sales, Consumption, Export, Import (2016-2021)
4.10 South America Antibody Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Antibody Market Analysis
5.1 North America Antibody Consumption and Value Analysis
5.1.1 North America Antibody Market Under COVID-19
5.2 North America Antibody Consumption Volume by Types
5.3 North America Antibody Consumption Structure by Application
5.4 North America Antibody Consumption by Top Countries
5.4.1 United States Antibody Consumption Volume from 2016 to 2021
5.4.2 Canada Antibody Consumption Volume from 2016 to 2021
5.4.3 Mexico Antibody Consumption Volume from 2016 to 2021
Chapter 6 East Asia Antibody Market Analysis
6.1 East Asia Antibody Consumption and Value Analysis
6.1.1 East Asia Antibody Market Under COVID-19
6.2 East Asia Antibody Consumption Volume by Types
6.3 East Asia Antibody Consumption Structure by Application
6.4 East Asia Antibody Consumption by Top Countries
6.4.1 China Antibody Consumption Volume from 2016 to 2021
6.4.2 Japan Antibody Consumption Volume from 2016 to 2021
6.4.3 South Korea Antibody Consumption Volume from 2016 to 2021
Chapter 7 Europe Antibody Market Analysis
7.1 Europe Antibody Consumption and Value Analysis
7.1.1 Europe Antibody Market Under COVID-19
7.2 Europe Antibody Consumption Volume by Types
7.3 Europe Antibody Consumption Structure by Application
7.4 Europe Antibody Consumption by Top Countries
7.4.1 Germany Antibody Consumption Volume from 2016 to 2021
7.4.2 UK Antibody Consumption Volume from 2016 to 2021
7.4.3 France Antibody Consumption Volume from 2016 to 2021
7.4.4 Italy Antibody Consumption Volume from 2016 to 2021
7.4.5 Russia Antibody Consumption Volume from 2016 to 2021
7.4.6 Spain Antibody Consumption Volume from 2016 to 2021
7.4.7 Netherlands Antibody Consumption Volume from 2016 to 2021
7.4.8 Switzerland Antibody Consumption Volume from 2016 to 2021
7.4.9 Poland Antibody Consumption Volume from 2016 to 2021
Chapter 8 South Asia Antibody Market Analysis
8.1 South Asia Antibody Consumption and Value Analysis
8.1.1 South Asia Antibody Market Under COVID-19
8.2 South Asia Antibody Consumption Volume by Types
8.3 South Asia Antibody Consumption Structure by Application
8.4 South Asia Antibody Consumption by Top Countries
8.4.1 India Antibody Consumption Volume from 2016 to 2021
8.4.2 Pakistan Antibody Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Antibody Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Antibody Market Analysis
9.1 Southeast Asia Antibody Consumption and Value Analysis
9.1.1 Southeast Asia Antibody Market Under COVID-19
9.2 Southeast Asia Antibody Consumption Volume by Types
9.3 Southeast Asia Antibody Consumption Structure by Application
9.4 Southeast Asia Antibody Consumption by Top Countries
9.4.1 Indonesia Antibody Consumption Volume from 2016 to 2021
9.4.2 Thailand Antibody Consumption Volume from 2016 to 2021
9.4.3 Singapore Antibody Consumption Volume from 2016 to 2021
9.4.4 Malaysia Antibody Consumption Volume from 2016 to 2021
9.4.5 Philippines Antibody Consumption Volume from 2016 to 2021
9.4.6 Vietnam Antibody Consumption Volume from 2016 to 2021
9.4.7 Myanmar Antibody Consumption Volume from 2016 to 2021
Chapter 10 Middle East Antibody Market Analysis
10.1 Middle East Antibody Consumption and Value Analysis
10.1.1 Middle East Antibody Market Under COVID-19
10.2 Middle East Antibody Consumption Volume by Types
10.3 Middle East Antibody Consumption Structure by Application
10.4 Middle East Antibody Consumption by Top Countries
10.4.1 Turkey Antibody Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Antibody Consumption Volume from 2016 to 2021
10.4.3 Iran Antibody Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Antibody Consumption Volume from 2016 to 2021
10.4.5 Israel Antibody Consumption Volume from 2016 to 2021
10.4.6 Iraq Antibody Consumption Volume from 2016 to 2021
10.4.7 Qatar Antibody Consumption Volume from 2016 to 2021
10.4.8 Kuwait Antibody Consumption Volume from 2016 to 2021
10.4.9 Oman Antibody Consumption Volume from 2016 to 2021
Chapter 11 Africa Antibody Market Analysis
11.1 Africa Antibody Consumption and Value Analysis
11.1.1 Africa Antibody Market Under COVID-19
11.2 Africa Antibody Consumption Volume by Types
11.3 Africa Antibody Consumption Structure by Application
11.4 Africa Antibody Consumption by Top Countries
11.4.1 Nigeria Antibody Consumption Volume from 2016 to 2021
11.4.2 South Africa Antibody Consumption Volume from 2016 to 2021
11.4.3 Egypt Antibody Consumption Volume from 2016 to 2021
11.4.4 Algeria Antibody Consumption Volume from 2016 to 2021
11.4.5 Morocco Antibody Consumption Volume from 2016 to 2021
Chapter 12 Oceania Antibody Market Analysis
12.1 Oceania Antibody Consumption and Value Analysis
12.2 Oceania Antibody Consumption Volume by Types
12.3 Oceania Antibody Consumption Structure by Application
12.4 Oceania Antibody Consumption by Top Countries
12.4.1 Australia Antibody Consumption Volume from 2016 to 2021
12.4.2 New Zealand Antibody Consumption Volume from 2016 to 2021
Chapter 13 South America Antibody Market Analysis
13.1 South America Antibody Consumption and Value Analysis
13.1.1 South America Antibody Market Under COVID-19
13.2 South America Antibody Consumption Volume by Types
13.3 South America Antibody Consumption Structure by Application
13.4 South America Antibody Consumption Volume by Major Countries
13.4.1 Brazil Antibody Consumption Volume from 2016 to 2021
13.4.2 Argentina Antibody Consumption Volume from 2016 to 2021
13.4.3 Columbia Antibody Consumption Volume from 2016 to 2021
13.4.4 Chile Antibody Consumption Volume from 2016 to 2021
13.4.5 Venezuela Antibody Consumption Volume from 2016 to 2021
13.4.6 Peru Antibody Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Antibody Consumption Volume from 2016 to 2021
13.4.8 Ecuador Antibody Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Antibody Business
14.1 Roche
14.1.1 Roche Company Profile
14.1.2 Roche Antibody Product Specification
14.1.3 Roche Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Johnson & Johnson
14.2.1 Johnson & Johnson Company Profile
14.2.2 Johnson & Johnson Antibody Product Specification
14.2.3 Johnson & Johnson Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Merck
14.3.1 Merck Company Profile
14.3.2 Merck Antibody Product Specification
14.3.3 Merck Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Novartis
14.4.1 Novartis Company Profile
14.4.2 Novartis Antibody Product Specification
14.4.3 Novartis Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 AbbVie
14.5.1 AbbVie Company Profile
14.5.2 AbbVie Antibody Product Specification
14.5.3 AbbVie Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Amgen
14.6.1 Amgen Company Profile
14.6.2 Amgen Antibody Product Specification
14.6.3 Amgen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Pfizer
14.7.1 Pfizer Company Profile
14.7.2 Pfizer Antibody Product Specification
14.7.3 Pfizer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Bayer
14.8.1 Bayer Company Profile
14.8.2 Bayer Antibody Product Specification
14.8.3 Bayer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Lilly
14.9.1 Lilly Company Profile
14.9.2 Lilly Antibody Product Specification
14.9.3 Lilly Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Bristol-Myers Squibb
14.10.1 Bristol-Myers Squibb Company Profile
14.10.2 Bristol-Myers Squibb Antibody Product Specification
14.10.3 Bristol-Myers Squibb Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 GlaxoSmithKline
14.11.1 GlaxoSmithKline Company Profile
14.11.2 GlaxoSmithKline Antibody Product Specification
14.11.3 GlaxoSmithKline Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Biogen
14.12.1 Biogen Company Profile
14.12.2 Biogen Antibody Product Specification
14.12.3 Biogen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 AstraZeneca
14.13.1 AstraZeneca Company Profile
14.13.2 AstraZeneca Antibody Product Specification
14.13.3 AstraZeneca Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Sanofi
14.14.1 Sanofi Company Profile
14.14.2 Sanofi Antibody Product Specification
14.14.3 Sanofi Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Alexion Pharmaceuticals
14.15.1 Alexion Pharmaceuticals Company Profile
14.15.2 Alexion Pharmaceuticals Antibody Product Specification
14.15.3 Alexion Pharmaceuticals Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Seattle Genetics
14.16.1 Seattle Genetics Company Profile
14.16.2 Seattle Genetics Antibody Product Specification
14.16.3 Seattle Genetics Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Antibody Market Forecast (2022-2027)
15.1 Global Antibody Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Antibody Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Antibody Value and Growth Rate Forecast (2022-2027)
15.2 Global Antibody Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Antibody Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Antibody Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Antibody Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Antibody Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Antibody Consumption Forecast by Type (2022-2027)
15.3.2 Global Antibody Revenue Forecast by Type (2022-2027)
15.3.3 Global Antibody Price Forecast by Type (2022-2027)
15.4 Global Antibody Consumption Volume Forecast by Application (2022-2027)
15.5 Antibody Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology


List of Tables and Figures

Figure Product Picture
Figure North America Antibody Revenue ($) and Growth Rate (2022-2027)
Figure United States Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Canada Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Mexico Antibody Revenue ($) and Growth Rate (2022-2027)
Figure East Asia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure China Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Japan Antibody Revenue ($) and Growth Rate (2022-2027)
Figure South Korea Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Europe Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Germany Antibody Revenue ($) and Growth Rate (2022-2027)
Figure UK Antibody Revenue ($) and Growth Rate (2022-2027)
Figure France Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Italy Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Russia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Spain Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Netherlands Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Switzerland Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Poland Antibody Revenue ($) and Growth Rate (2022-2027)
Figure South Asia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure India Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Pakistan Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Bangladesh Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Southeast Asia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Indonesia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Thailand Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Singapore Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Malaysia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Philippines Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Vietnam Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Myanmar Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Middle East Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Turkey Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Saudi Arabia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Iran Antibody Revenue ($) and Growth Rate (2022-2027)
Figure United Arab Emirates Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Israel Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Iraq Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Qatar Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Kuwait Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Oman Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Africa Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Nigeria Antibody Revenue ($) and Growth Rate (2022-2027)
Figure South Africa Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Egypt Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Oceania Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Australia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure New Zealand Antibody Revenue ($) and Growth Rate (2022-2027)
Figure South America Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Brazil Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Argentina Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Columbia Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Chile Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Venezuela Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Peru Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Puerto Rico Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Ecuador Antibody Revenue ($) and Growth Rate (2022-2027)
Figure Global Antibody Market Size Analysis from 2022 to 2027 by Consumption Volume
Figure Global Antibody Market Size Analysis from 2022 to 2027 by Value
Table Global Antibody Price Trends Analysis from 2022 to 2027
Table Global Antibody Consumption and Market Share by Type (2016-2021)
Table Global Antibody Revenue and Market Share by Type (2016-2021)
Table Global Antibody Consumption and Market Share by Application (2016-2021)
Table Global Antibody Revenue and Market Share by Application (2016-2021)
Table Global Antibody Consumption and Market Share by Regions (2016-2021)
Table Global Antibody Revenue and Market Share by Regions (2016-2021)
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Major Manufacturers Capacity and Total Capacity
Table 2016-2021 Major Manufacturers Capacity Market Share
Table 2016-2021 Major Manufacturers Production and Total Production
Table 2016-2021 Major Manufacturers Production Market Share
Table 2016-2021 Major Manufacturers Revenue and Total Revenue
Table 2016-2021 Major Manufacturers Revenue Market Share
Table 2016-2021 Regional Market Capacity and Market Share
Table 2016-2021 Regional Market Production and Market Share
Table 2016-2021 Regional Market Revenue and Market Share
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table Global Antibody Consumption by Regions (2016-2021)
Figure Global Antibody Consumption Share by Regions (2016-2021)
Table North America Antibody Sales, Consumption, Export, Import (2016-2021)
Table East Asia Antibody Sales, Consumption, Export, Import (2016-2021)
Table Europe Antibody Sales, Consumption, Export, Import (2016-2021)
Table South Asia Antibody Sales, Consumption, Export, Import (2016-2021)
Table Southeast Asia Antibody Sales, Consumption, Export, Import (2016-2021)
Table Middle East Antibody Sales, Consumption, Export, Import (2016-2021)
Table Africa Antibody Sales, Consumption, Export, Import (2016-2021)
Table Oceania Antibody Sales, Consumption, Export, Import (2016-2021)
Table South America Antibody Sales, Consumption, Export, Import (2016-2021)
Figure North America Antibody Consumption and Growth Rate (2016-2021)
Figure North America Antibody Revenue and Growth Rate (2016-2021)
Table North America Antibody Sales Price Analysis (2016-2021)
Table North America Antibody Consumption Volume by Types
Table North America Antibody Consumption Structure by Application
Table North America Antibody Consumption by Top Countries
Figure United States Antibody Consumption Volume from 2016 to 2021
Figure Canada Antibody Consumption Volume from 2016 to 2021
Figure Mexico Antibody Consumption Volume from 2016 to 2021
Figure East Asia Antibody Consumption and Growth Rate (2016-2021)
Figure East Asia Antibody Revenue and Growth Rate (2016-2021)
Table East Asia Antibody Sales Price Analysis (2016-2021)
Table East Asia Antibody Consumption Volume by Types
Table East Asia Antibody Consumption Structure by Application
Table East Asia Antibody Consumption by Top Countries
Figure China Antibody Consumption Volume from 2016 to 2021
Figure Japan Antibody Consumption Volume from 2016 to 2021
Figure South Korea Antibody Consumption Volume from 2016 to 2021
Figure Europe Antibody Consumption and Growth Rate (2016-2021)
Figure Europe Antibody Revenue and Growth Rate (2016-2021)
Table Europe Antibody Sales Price Analysis (2016-2021)
Table Europe Antibody Consumption Volume by Types
Table Europe Antibody Consumption Structure by Application
Table Europe Antibody Consumption by Top Countries
Figure Germany Antibody Consumption Volume from 2016 to 2021
Figure UK Antibody Consumption Volume from 2016 to 2021
Figure France Antibody Consumption Volume from 2016 to 2021
Figure Italy Antibody Consumption Volume from 2016 to 2021
Figure Russia Antibody Consumption Volume from 2016 to 2021
Figure Spain Antibody Consumption Volume from 2016 to 2021
Figure Netherlands Antibody Consumption Volume from 2016 to 2021
Figure Switzerland Antibody Consumption Volume from 2016 to 2021
Figure Poland Antibody Consumption Volume from 2016 to 2021
Figure South Asia Antibody Consumption and Growth Rate (2016-2021)
Figure South Asia Antibody Revenue and Growth Rate (2016-2021)
Table South Asia Antibody Sales Price Analysis (2016-2021)
Table South Asia Antibody Consumption Volume by Types
Table South Asia Antibody Consumption Structure by Application
Table South Asia Antibody Consumption by Top Countries
Figure India Antibody Consumption Volume from 2016 to 2021
Figure Pakistan Antibody Consumption Volume from 2016 to 2021
Figure Bangladesh Antibody Consumption Volume from 2016 to 2021
Figure Southeast Asia Antibody Consumption and Growth Rate (2016-2021)
Figure Southeast Asia Antibody Revenue and Growth Rate (2016-2021)
Table Southeast Asia Antibody Sales Price Analysis (2016-2021)
Table Southeast Asia Antibody Consumption Volume by Types
Table Southeast Asia Antibody Consumption Structure by Application
Table Southeast Asia Antibody Consumption by Top Countries
Figure Indonesia Antibody Consumption Volume from 2016 to 2021
Figure Thailand Antibody Consumption Volume from 2016 to 2021
Figure Singapore Antibody Consumption Volume from 2016 to 2021
Figure Malaysia Antibody Consumption Volume from 2016 to 2021
Figure Philippines Antibody Consumption Volume from 2016 to 2021
Figure Vietnam Antibody Consumption Volume from 2016 to 2021
Figure Myanmar Antibody Consumption Volume from 2016 to 2021
Figure Middle East Antibody Consumption and Growth Rate (2016-2021)
Figure Middle East Antibody Revenue and Growth Rate (2016-2021)
Table Middle East Antibody Sales Price Analysis (2016-2021)
Table Middle East Antibody Consumption Volume by Types
Table Middle East Antibody Consumption Structure by Application
Table Middle East Antibody Consumption by Top Countries
Figure Turkey Antibody Consumption Volume from 2016 to 2021
Figure Saudi Arabia Antibody Consumption Volume from 2016 to 2021
Figure Iran Antibody Consumption Volume from 2016 to 2021
Figure United Arab Emirates Antibody Consumption Volume from 2016 to 2021
Figure Israel Antibody Consumption Volume from 2016 to 2021
Figure Iraq Antibody Consumption Volume from 2016 to 2021
Figure Qatar Antibody Consumption Volume from 2016 to 2021
Figure Kuwait Antibody Consumption Volume from 2016 to 2021
Figure Oman Antibody Consumption Volume from 2016 to 2021
Figure Africa Antibody Consumption and Growth Rate (2016-2021)
Figure Africa Antibody Revenue and Growth Rate (2016-2021)
Table Africa Antibody Sales Price Analysis (2016-2021)
Table Africa Antibody Consumption Volume by Types
Table Africa Antibody Consumption Structure by Application
Table Africa Antibody Consumption by Top Countries
Figure Nigeria Antibody Consumption Volume from 2016 to 2021
Figure South Africa Antibody Consumption Volume from 2016 to 2021
Figure Egypt Antibody Consumption Volume from 2016 to 2021
Figure Algeria Antibody Consumption Volume from 2016 to 2021
Figure Algeria Antibody Consumption Volume from 2016 to 2021
Figure Oceania Antibody Consumption and Growth Rate (2016-2021)
Figure Oceania Antibody Revenue and Growth Rate (2016-2021)
Table Oceania Antibody Sales Price Analysis (2016-2021)
Table Oceania Antibody Consumption Volume by Types
Table Oceania Antibody Consumption Structure by Application
Table Oceania Antibody Consumption by Top Countries
Figure Australia Antibody Consumption Volume from 2016 to 2021
Figure New Zealand Antibody Consumption Volume from 2016 to 2021
Figure South America Antibody Consumption and Growth Rate (2016-2021)
Figure South America Antibody Revenue and Growth Rate (2016-2021)
Table South America Antibody Sales Price Analysis (2016-2021)
Table South America Antibody Consumption Volume by Types
Table South America Antibody Consumption Structure by Application
Table South America Antibody Consumption Volume by Major Countries
Figure Brazil Antibody Consumption Volume from 2016 to 2021
Figure Argentina Antibody Consumption Volume from 2016 to 2021
Figure Columbia Antibody Consumption Volume from 2016 to 2021
Figure Chile Antibody Consumption Volume from 2016 to 2021
Figure Venezuela Antibody Consumption Volume from 2016 to 2021
Figure Peru Antibody Consumption Volume from 2016 to 2021
Figure Puerto Rico Antibody Consumption Volume from 2016 to 2021
Figure Ecuador Antibody Consumption Volume from 2016 to 2021
Roche Antibody Product Specification
Roche Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Johnson & Johnson Antibody Product Specification
Johnson & Johnson Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Merck Antibody Product Specification
Merck Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Novartis Antibody Product Specification
Table Novartis Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AbbVie Antibody Product Specification
AbbVie Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Amgen Antibody Product Specification
Amgen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Pfizer Antibody Product Specification
Pfizer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bayer Antibody Product Specification
Bayer Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Lilly Antibody Product Specification
Lilly Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bristol-Myers Squibb Antibody Product Specification
Bristol-Myers Squibb Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GlaxoSmithKline Antibody Product Specification
GlaxoSmithKline Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Biogen Antibody Product Specification
Biogen Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
AstraZeneca Antibody Product Specification
AstraZeneca Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi Antibody Product Specification
Sanofi Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Alexion Pharmaceuticals Antibody Product Specification
Alexion Pharmaceuticals Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Seattle Genetics Antibody Product Specification
Seattle Genetics Antibody Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Figure Global Antibody Consumption Volume and Growth Rate Forecast (2022-2027)
Figure Global Antibody Value and Growth Rate Forecast (2022-2027)
Table Global Antibody Consumption Volume Forecast by Regions (2022-2027)
Table Global Antibody Value Forecast by Regions (2022-2027)
Figure North America Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure North America Antibody Value and Growth Rate Forecast (2022-2027)
Figure United States Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure United States Antibody Value and Growth Rate Forecast (2022-2027)
Figure Canada Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Canada Antibody Value and Growth Rate Forecast (2022-2027)
Figure Mexico Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Mexico Antibody Value and Growth Rate Forecast (2022-2027)
Figure East Asia Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure East Asia Antibody Value and Growth Rate Forecast (2022-2027)
Figure China Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure China Antibody Value and Growth Rate Forecast (2022-2027)
Figure Japan Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Japan Antibody Value and Growth Rate Forecast (2022-2027)
Figure South Korea Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure South Korea Antibody Value and Growth Rate Forecast (2022-2027)
Figure Europe Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Europe Antibody Value and Growth Rate Forecast (2022-2027)
Figure Germany Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Germany Antibody Value and Growth Rate Forecast (2022-2027)
Figure UK Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure UK Antibody Value and Growth Rate Forecast (2022-2027)
Figure France Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure France Antibody Value and Growth Rate Forecast (2022-2027)
Figure Italy Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Italy Antibody Value and Growth Rate Forecast (2022-2027)
Figure Russia Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Russia Antibody Value and Growth Rate Forecast (2022-2027)
Figure Spain Antibody Consumption and Growth Rate Forecast (2022-2027)
Figure Spain Antibody Value and Growth Rate
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs